On July 14th, Huada Gene created a big news with “one touch of redâ€. After a wave of listings, the dust finally settled. With the 2001th bell of the Shenzhen Stock Exchange, Huada Gene became the first in the domestic genetic industry. A company that does not borrow backdoors to register A shares.
In today's era of the booming genetic industry, the listing of Huada Gene can be said to be on the cusp of the turmoil. On the same day, its listing bidding stage opened up 20%, and the continuous bidding stage soared 32%. After the resumption of trading, it surged 43.99%. 19.64 yuan / share. Previously, Yin Wei, general manager of Huada Gene, pointed out in an interview with 澎湃News that the rumors of genetic testing and gene sequencing were made by Huada Gene. The high valuation of the gene company was started from the Huada gene. Standing on the cusp of capital, "it is better to wait for others to let the wind out than to blow."
On the listing, Huada Gene has indeed experienced a hurricane. On July 13, the long-awaited precision medical concept stocks rose one after another. Rongzhilian and Zhongyuan Concord have daily limit, Daan Gene, *ST Tianyi, Qianshan Pharmaceutical Machine The increase in Anke Bio, Zixin Pharmaceutical and Shuanglu Pharmaceuticals exceeded 4%. Wang Kesheng, manager of Beijing Novo Zhiyuan Genetics Department, told the reporter, “From a macro perspective, the listing of Huada Gene is very good for the entire genetic industry.â€
On the day of the listing, Yin Wei said: "Gene detection is not only high, but also grounding gas. Accurate treatment cannot be elite medical treatment . It should be Pratt & Whitney Medical. We should make every test very convenient and affordable. "But it is easy to say that the road is difficult to go." At present, the genetic testing industry is very lively, and the Huada Gene faces fierce competition. Huada admits in the prospectus that the primary risk is the risk of increased market competition. “The genomics application industry is one of the fastest growing high-tech industries. A large number of gene sequencing service providers for basic research and clinical and medical genetic testing service providers for end users have emerged on the market. The competition in the sequencing industry, especially in domestic mature products and services, has become increasingly fierce."
At present, genetic testing is mainly used in the medical field, and is mainly concentrated in the fields of reproductive health and tumor diagnosis and treatment. Non-invasive prenatal screening is China's first second-generation sequencing product approved for clinical use, and is the most mature part of the genetic industry; and tumor diagnosis and treatment is considered to be the next blue ocean, and companies are competing for layout.
So, in the field of genetic testing, what is the player of Huada Gene?
Focus on reproductive health, cancer and infectious diseases
"We have never been one, the boss is the boss, and Huada is the boss." On the day of the listing, when answering the reporter's question, Wang Jian, founder and chairman of Huada Gene, said.
How big is the Huada gene, which is often confusing. In terms of mass, Huada Gene is indeed the well-deserved industry leader. As a leading enterprise in the domestic genetic industry, Huada Gene has laid out the entire industrial chain of gene sequencing, including upstream sequencers and reagents, and gene sequencing services provided by the middle and lower reaches. And has advantages in non-invasive birth control, PGS/PGD, tumor diagnosis and treatment, and accompanying diagnosis. Liu Mingyu, a partner of Hechuang Capital, told reporters that "the biggest contribution of Huada Gene is to bring the gene sequencing to China in advance, and to promote it to clinical applications and create an industrial cluster."
According to the "Prospectus", at present, the genetic business of Huada mainly includes reproductive health, basic research, complex diseases, and drug research and development. Among them, reproductive health service revenue has increased year by year, accounting for 54.62% of total revenue; basic research Service revenue has declined year after year. According to public reports, Huada Gene is the world's largest second-generation sequencer. In contrast, Down's syndrome genetic testing prenatal screening, Huada's genes account for half of the global total.
As the cost of second-generation gene sequencing has dropped drastically, the gene sequencing service of “Wang Yutang Qian Yan†has also “flyed into the homes of ordinary peopleâ€. Yin Wei has said that in the clinical application of genes most concerned by the public, Huada Gene is currently focusing on reproductive health genetic testing, detection and intervention of tumor genes, and genetic testing of infectious diseases.
YELLOW COLOR VACUMMN FRESH WAXY CORN FOR HUMAN EATTING , SWEET CORN PLANTED IN INNER MONGOLIA CHINA.
VACUMMN FRESH WAXY CORN FOR HUMAN EATTING
Wuyuan county dafeng oil food co.,ltd , https://www.dafengfood.com.cn